Pharmafile Logo

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111

 Latest Content from PMHub 

Intellus Worldwide Summit 2018

Visit us on stand number 413

How buyer insights supported the development of an effective market strategy

Our client was developing a new product for HIV and needed to understand buyer willingness to pay in the emerging markets of South Africa, Kenya, and India. They needed to...

Lucid Group Appoints a New HR Business Partner

Carol Daniel joins Lucid as their new HR Business Partner. Carol will work closely with the managing directors from each of the Lucid Group companies to lead the people plan...

How will new data protection law affect pharma?

Sarah Eglington, of Wilmington Healthcare, explores how GDPR will change pharma’s relationship with healthcare professionals

Barber shops provide a short cut to BP reduction

As well as a haircut, barbers can shave millimetres off men's blood pressure

What’s the secret to leadership in joint working?

Dovetail Director Claire Munro on effective leadership strategies that drive results in joint working between pharma and clinical groups.

Lucid Group – Hanging tough in support of Wycombe Homeless Connection

This Saturday, 19 brave Lucidians took to the fields of Henley to conquer the first of Tough Mudder’s 2018 obstacle course events. The Tough Mudder course features 13 obstacles over...

Empowered patients improve outcomes

This white paper co-authored by our own Caroline Benson and Guy Yeoman, MediPaCe, discusses why non-adherence is occurring, how patients’ can be better engaged with their conditions and treatments and...